SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Dadra Facility Receives Warning Letter From US FDA

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1688.6000 9.50 (0.57%)

NSE Oct 20, 2025 15:31 PM

52W Low on Sep 26, 2025

Volume: 1.6M

Sun Pharmaceutical Industries Ltd.

19 Jun 2024, 08:50PM

1688.60

0.57%

Company Update

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Intimation regarding Warning Letter from US FDA

More from Sun Pharmaceutical Industries Ltd.

Recommended

Market closes higher, Reliance Industries' Q2FY26 net profit grows 10% YoY

Trendlyne Marketwatch | 20 Oct 2025, 03:57PM

Five Interesting Stocks Today - October 17, 2025

The Baseline | 17 Oct 2025

Change is hard, and some Indian pharma companies are embracing it better than others